Physician profile
Moneesh Deepak Bhow
NPI 1215986096
$77,685.63
in general payments reported to CMS, 2019-2025
19 companies · $470 in 2025
The $470 reported for 2025 was more than what 92% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $3,411 · 2021: $15K · 2022: $17K · 2023: $5,460 · 2024: $16K · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $3,571 · Food and Beverage: $2,679 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,775.00 |
| Travel and Lodging | $3,570.77 |
| Food and Beverage | $2,678.56 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $75,167.71 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $612.16 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbvie INC. | $373.70 | 2021-2024 | Dalvance |
| Bardy Diagnostics, INC. | $300.00 | 2022 | |
| Abbott Laboratories | $188.90 | 2023 | Prodigy |
| Stryker Corporation | $185.38 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $155.12 | 2023-2025 | Indigo System |
| Ceribell, INC. | $133.74 | 2025 | Pocket Eeg Device |
| Csl Behring | $108.21 | 2019-2024 | Kcentra |
| Atricure, INC. | $105.35 | 2022-2024 | |
| Medical Device Business Services, INC. | $97.58 | 2022 | |
| Pfizer INC. | $63.79 | 2022-2025 | |
| Biosense Webster, INC. | $56.83 | 2019-2022 | |
| Allergan, INC. | $30.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $28.41 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $27.04 | 2022 | |
| Rare Disease Therapeutics, INC. | $19.77 | 2024 | Anavip |
| Bioxcel Therapeutics, INC. | $19.43 | 2023 | Igalmi |
| Paratek Pharmaceuticals, INC. | $12.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moneesh Bhow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.